How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

ETFs allow investing in diverse portfolios through a single transaction, simplifying diversified investing. Differences between ETFs and mutual funds include trading dynamics and pricing structures.

Clint Proctor is a managing editor with the credit cards and travel rewards team at Forbes Advisor. He has eight years of experience in personal finance journalism and has contributed to a variety of ...